Detalhe da pesquisa
1.
Effectiveness of the Ad26.COV2.S vaccine in health-care workers in South Africa (the Sisonke study): results from a single-arm, open-label, phase 3B, implementation study.
Lancet
; 399(10330): 1141-1153, 2022 03 19.
Artigo
Inglês
| MEDLINE | ID: mdl-35305740
2.
Safety evaluation of the single-dose Ad26.COV2.S vaccine among healthcare workers in the Sisonke study in South Africa: A phase 3b implementation trial.
PLoS Med
; 19(6): e1004024, 2022 06.
Artigo
Inglês
| MEDLINE | ID: mdl-35727802